Mapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis

dc.contributor.authorBilbao, Amaia
dc.contributor.authorMartín Fernández, Jesús
dc.contributor.authorGarcía-Pérez, Lidia
dc.contributor.authorArenaza, Juan Carlos
dc.contributor.authorAriza-Cardiel, Gloria
dc.contributor.authorRamallo-Fariña, Yolanda
dc.contributor.authorAnsola, Laura
dc.date.accessioned2025-01-02T08:48:05Z
dc.date.available2025-01-02T08:48:05Z
dc.date.issued2020-03
dc.descriptionThis study was supported by grants from the Carlos III Health Institute (Refs: PI13/00560, PI13/00518 and PI13/00648) and the European Regional Development Fund.
dc.description.abstractObjectives: To map the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) onto the EQ-5D-5L in patients with hip or knee osteoarthritis (OA). Methods: A prospective observational study was conducted on 758 patients with hip or knee OA who completed the EQ-5D-5L and WOMAC questionnaires, of whom 644 completed them both again 6 months later. Baseline data were used to derive mapping functions. Generalized additive models were used to identify to which powers the WOMAC subscales should be raised to achieve a linear relationship with the response. For the modeling, general linear models (GLM), Tobit models, and beta regression models were used. Age, sex, and affected joints were also considered. Preferred models were selected based on Akaike and Bayesian information criteria, adjusted R2, mean absolute error (MAE), and root mean squared error (RMSE). The functions were validated with the follow-up data using MAE, RMSE, and the intraclass correlation coefficient. Results: The preferred models were a GLM with Pain2+Pain3+Function+Pain·Function as covariates and a beta model with Pain3+Function+Function2+Function3 as covariates. The adjusted R2 were similar (0.6190 and 0.6136, respectively). The predictive performance of these models in the validation sample was similar and both models showed an overprediction for health states worse than death. Conclusion: To our knowledge, these are the first functions mapping the WOMAC onto the EQ-5D-5L in patients with hip or knee OA. They showed an acceptable fit and precision and could be very useful for clinicians and researchers when cost-effectiveness studies are needed and generic preference-based health-related quality of life instruments to derive utilities are not available.
dc.identifier.citationBilbao A, Martín-Fernández J, García-Pérez L, Arenaza JC, Ariza-Cardiel G, Ramallo-Fariña Y, Ansola L. Mapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis. Value Health. 2020 Mar;23(3):379-387. doi: 10.1016/j.jval.2019.09.2755. Epub 2019 Nov 8. PMID: 32197734.
dc.identifier.doi10.1016/j.jval.2019.09.2755
dc.identifier.issn1524-4733 (online)
dc.identifier.issn1098-3015 (print)
dc.identifier.urihttps://hdl.handle.net/10115/49637
dc.language.isoen
dc.publisherElsevier
dc.rights.accessRightsinfo:eu-repo/semantics/closedAccess
dc.subjectEQ-5D
dc.subjectWOMAC
dc.subjectmapping
dc.subjectosteoarthritis
dc.subjectutility index
dc.titleMapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis
dc.typeArticle

Archivos

Bloque original

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Value in Health 2020.pdf
Tamaño:
829.16 KB
Formato:
Adobe Portable Document Format